Key result
Use of the right gastroepiploic artery as a coronary artery bypass graft demonstrated an in-hospital mortality of 1.6% and a mid-term angiographic patency rate of 91.8%.
Why the study?
Does the use of the right gastroepiploic artery as a coronary artery bypass graft provide acceptable clinical outcomes and patency in patients undergoing coronary surgery?
Population
307 patients undergoing coronary artery bypass surgery, average age 56.5 years, 89% male. Included 8.5%…
Design
Cohort
Follow-up
average 26 months (range 6-88)
Authors
Loading...
Supports right gastroepiploic artery as bypass conduit option; leaves open need for randomized trials versus standard arterial grafts.
Observational (n=307)
Does the use of the right gastroepiploic artery as a coronary artery bypass graft provide acceptable clinical outcomes and patency in patients undergoing coronary surgery?
The right gastroepiploic artery can be safely used as a coronary artery bypass graft with low mortality, low morbidity, and high mid-term patency rates.
Alberto Albertini (1998) conducted an observational in Coronary artery disease requiring bypass surgery (n=307). Right gastroepiploic artery graft was evaluated on In-hospital mortality. Use of the right gastroepiploic artery as a coronary artery bypass graft demonstrated an in-hospital mortality of 1.6% and a mid-term angiographic patency rate of 91.8%.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: